As global markets continue to react to political developments and economic indicators, major indexes like the S&P 500 have reached new highs amid optimism over potential trade deals and AI investments ...

SEOUL, Jan. 15 (Yonhap) -- SK Biopharmaceuticals Co. (SK Biopharm), a biopharmaceutical arm of SK Group, will establish a joint venture with a major South American biopharma, Eurofarma, in the United ...

Meanwhile, another Korean biotech, SK Biopharmaceuticals, signed a deal with Brazil’s Eurofarma to set up a joint venture in the U.S. to develop an epilepsy treatment platform based on ...

SAN FRANCISCO -- SK Biopharmaceuticals plans to establish a joint venture with Eurofarma, one of Latin America’s leading pharmaceutical companies, to commercialize a new AI-based epilepsy ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

With its stock down 18% over the past three months, it is easy to disregard NeuroScientific Biopharmaceuticals (ASX:NSB). We, however decided to study the company's financials to determine if they ...

1 Day 326030 0.09% DJIA 0.34% S&P 500 -0.40% Health Care/Life Sciences 0.43% ...

HANGZHOU, China--(BUSINESS WIRE)--HighField Biopharmaceuticals, a clinical stage company using lipid-based therapeutics to treat cancer and other diseases, announced today publication of two ...